Maurits Wolleswinkel, EVP Marketing and Strategy at Elekta, added, “This landmark case demonstrates that Leksell Gamma Knife Icon is a diverse treatment option, suitable for a wide variety of patients. Icon enables extremely precise dose delivery in frame-based or frameless configurations, and substantially lowers radiation exposure to the entire body. Additionally, Icon enables an online adaptive workflow, ensuring that treatment is delivered as planned for every patient session.”
For more information on how Gamma Knife Icon works, visit www.careforthebrain.com.
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
###
----------------------------------------------------------------------
[1] Stieler F, Wenz F, Abo-madyan Y, et al. Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT). Strahlenther Onkol. 2016.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Back to HCB News
